Heart Failure With Preserved Ejection Fraction: How far we have Come: A Brief Report From Two Outstanding Educational Events

Not long ago, the concept that patients could experience heart failure without having left ventricular systolic dysfunction was considered an exception rather than the rule. Now, heart failure with preserved ejection fraction (HFpEF) is recognized as a common, if not the most prevalent, form of heart failure. During the past weeks, I had the privilege to participate in two outstanding educational events focused on HFpEF: the 2025 HFpEF Summit organized by David Lefer, PhD (Cedars-Sinai Medical Center, Los Angeles, CA) and Fadi Salloum, PhD (Virginia Commonwealth University, Richmond, VA), and the UPenn HFpEF Symposium 2025 led by Payman Zamani, MD, and Stuart Prenner, MD (University of Pennsylvania, Philadelphia, PA). I truly enjoyed these sessions and left with a sense of satisfaction and optimism. Indeed, while there is a lot left to discover and develop in HFpEF, so much progress has been made since the first iterations of these meetings, both now in their third edition.